๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical usefulness of adoptive immunotherapy using autologous lymphokine-activated killer cells for temozolomide-induced lymphopenia of glioblastoma patients

โœ Scribed by Sumida, M.; Yoshioka, E.; Yamamoto, A.; Kanematsu, D.; Furuya, Y.; Fukusumi, H.; Takada, A.; Nonaka, M.; Nakajima, S.; Mori, K.; Goto, S.; Kamigaki, T.; Maekawa, R.; Shofuda, T.; Moriuchi, S.; Yamasaki, M.; Kanemura, Y.

Book ID
123476604
Publisher
Informa plc
Year
2013
Tongue
English
Weight
61 KB
Volume
15
Category
Article
ISSN
1465-3249

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Adoptive immunotherapy for recurrent gli
Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2
โœ Randall E. Merchant; Angus J. Grant; Lynn H. Merchant; Harold F. Young ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 565 KB

Thirteen patients with recurrent glioblastoma were treated with adoptively transferred autologous lymphokine activated killer (LAK) cells and recombinant interleukin-2 (rIL-2). Patients' blood mononuclear cells (MNC) obtained by leukapheresis were cultured at 2.5 million MNC per ml for 3 to 5 days i

The requirements for successful immunoth
The requirements for successful immunotherapy of intraperitoneal cancer using interleukin-2 and lymphokine-activated killer cells
โœ Reyer T. Ottow; Alexander M. M. Eggermont; E. Philip Steller; Paul H. Sugarbaker ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 907 KB

In a significant proportion of patients with gastrointestinal and ovarian malignancy the peritoneal cavity is a prominent site at which surgical treatment fails. Adjuvant treatments directed at this site should be investigated in an attempt to improve survival in patients with these cancers. In the